The Role of Structure MRI in Diagnosing Autism

Review of structural neuroimaging and genetic findings in autism spectrum disorder - a clinical perspective

Autism spectrum disorders (ASDs) are neurodevelopmental conditions characterized by deficits in social relationships and communication and restrictive, repetitive behaviors and interests. ASDs form a heterogeneous group from a clinical and genetic perspective. Currently, ASDs diagnosis is based on the clinical observation of the individual's behavior. The subjective nature of behavioral diagnoses, in the context of ASDs heterogeneity, contributes to significant variation in the age at ASD diagnosis. Early detection has been proved to be critical in ASDs, as early start of appropriate therapeutic interventions greatly improve the outcome for some children. Structural magnetic resonance imaging (MRI) is widely used in the diagnostic work-up of neurodevelopmental conditions, including ASDs, mostly for brain malformations detection. Recently, the focus of brain imaging shifted towards quantitative MRI parameters, aiming to identify subtle changes that may establish early detection biomarkers. ASDs have a strong genetic component; deletions and duplications of several genomic loci have been strongly associated with ASDs risk. Consequently, a multitude of neuroimaging and genetic findings emerged in ASDs in the recent years. The association of gross or subtle changes in brain morphometry and volumes with different genetic defects has the potential to bring new insights regarding normal development and pathomechanisms of various disorders affecting the brain. Still, the clinical implications of these discoveries and the impact of genetic abnormalities on brain structure and function are unclear. Here we review the literature on brain imaging correlated with the most prevalent genomic imbalances in ASD, and discuss the potential clinical impact.

Enhanced detection of autism spectrum disorder through neuroimaging data using stack classifier ensembled with modified VGG-19

BackgroundAutism spectrum disorder (ASD) is a neurodevelopmental disease marked by a variety of repetitive behaviors and social communication difficulties.PurposeTo develop a generalizable machine learning (ML) classifier that can accurately and effectively predict ASD in children.Material and MethodsThis paper makes use of neuroimaging data from the Autism Brain Imaging Data Exchange (ABIDE I and II) datasets through a combination of structural and functional magnetic resonance imaging data. Several ML models, such as Support Vector Machines (SVM), CatBoost, random forest (RF), and stack classifiers, were tested to demonstrate which model performs the best in ASD classification when used alongside a deep convolutional neural network.ResultsResults showed that stack classifier performed the best among the models, with the highest accuracy of 81.68%, sensitivity of 85.08%, and specificity of 79.13% for ABIDE I, and 81.34%, 83.61%, and 82.21% for ABIDE II, showing its superior ability to identify complex patterns in neuroimaging data. SVM performed poorly across all metrics, showing its limitations in dealing with high-dimensional neuroimaging data.ConclusionThe results show that the application of ML models, especially ensemble approaches like stack classifier, holds significant promise in improving the accuracy with which ASD is detected using neuroimaging and thus shows their potential for use in clinical applications and early intervention strategies.

AI-based non-invasive imaging technologies for early autism spectrum disorder diagnosis: A short review and future directions

Autism Spectrum Disorder (ASD) is a neurological condition, with recent statistics from the CDC indicating a rising prevalence of ASD diagnoses among infants and children. This trend emphasizes the critical importance of early detection, as timely diagnosis facilitates early intervention and enhances treatment outcomes. Consequently, there is an increasing urgency for research to develop innovative tools capable of accurately and objectively identifying ASD in its earliest stages. This paper offers a short overview of recent advancements in non-invasive technology for early ASD diagnosis, focusing on an imaging modality, structural MRI technique, which has shown promising results in early ASD diagnosis. This brief review aims to address several key questions: (i) Which imaging radiomics are associated with ASD? (ii) Is the parcellation step of the brain cortex necessary to improve the diagnostic accuracy of ASD? (iii) What databases are available to researchers interested in developing non-invasive technology for ASD? (iv) How can artificial intelligence tools contribute to improving the diagnostic accuracy of ASD? Finally, our review will highlight future trends in ASD diagnostic efforts.

Synapse and primary cilia dysfunctions in Autism Spectrum Disorders. Avenues to normalize these functions

AIM

An update on the plasticity of the brain networks involved in autism (autism spectrum disorders [ASD]), and the increasing role of their synapses and primary non-motile cilia.

METHODS

Data from PubMed and Google on this subject, published until February 2024, were analyzed.

RESULTS

Structural and functional brain characteristics and genetic particularities involving synapses and cilia that modify neuronal circuits are observed in ASD, such as reduced pruning of dendrites, minicolumnar pathology, or persistence of connections usually doomed to disappear. Proteins involved in synapse functions (such as neuroligins and neurexins), in the postsynaptic architectural scaffolding (such as Shank proteins) or in cilia functions (such as IFT-independent kinesins) are often abnormal. There is an increase in glutaminergic transmission and a decrease in GABA inhibition. ASD may occur in genetic ciliopathies. The means of modulating these specificities, when deemed useful, are described.

INTERPRETATION

The wide range of clinical manifestations of ASD is strongly associated with abnormalities in the morphology, functions, and plasticity of brain networks, involving their synapses and non-motile cilia. Their modulation offers important research perspectives on treatments when needed, especially since brain plasticity persists much later than previously thought. Improved early detection of ASD and additional studies on synapses and primary cilia are needed.

Exploring the most discriminative brain structural abnormalities in ASD with multi-stage progressive feature refinement approach

Objective

Autism spectrum disorder (ASD) is a neurodevelopmental condition characterized by increasing prevalence, diverse impairments, and unclear origins and mechanisms. To gain a better grasp of the origins of ASD, it is essential to identify the most distinctive structural brain abnormalities in individuals with ASD.

Methods

A Multi-Stage Progressive Feature Refinement Approach was employed to identify the most pivotal structural magnetic resonance imaging (MRI) features that distinguish individuals with ASD from typically developing (TD) individuals. The study included 175 individuals with ASD and 69 TD individuals, all aged between 7 and 18 years, matched in terms of age and gender. Both cortical and subcortical features were integrated, with a particular focus on hippocampal subfields.

Results

Out of 317 features, 9 had the most significant impact on distinguishing ASD from TD individuals. These structural features, which include a specific hippocampal subfield, are closely related to the brain areas associated with the reward system.

Conclusion

Structural irregularities in the reward system may play a crucial role in the pathophysiology of ASD, and specific hippocampal subfields may also contribute uniquely, warranting further investigation.

Bridging Genetic Insights with Neuroimaging in Autism Spectrum Disorder-A Systematic Review

Autism Spectrum Disorder (ASD) is an early onset neurodevelopmental disorder characterized by impaired social interaction and communication, and repetitive patterns of behavior. Family studies show that ASD is highly heritable, and hundreds of genes have previously been implicated in the disorder; however, the etiology is still not fully clear. Brain imaging and electroencephalography (EEG) are key techniques that study alterations in brain structure and function. Combined with genetic analysis, these techniques have the potential to help in the clarification of the neurobiological mechanisms contributing to ASD and help in defining novel therapeutic targets. To further understand what is known today regarding the impact of genetic variants in the brain alterations observed in individuals with ASD, a systematic review was carried out using Pubmed and EBSCO databases and following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. This review shows that specific genetic variants and altered patterns of gene expression in individuals with ASD may have an effect on brain circuits associated with face processing and social cognition, and contribute to excitation-inhibition imbalances and to anomalies in brain volumes.

Do it the transformer way: A comprehensive review of brain and vision transformers for autism spectrum disorder diagnosis and classification

Autism spectrum disorder (ASD) is a condition observed in children who display abnormal patterns of interaction, behavior, and communication with others. Despite extensive research efforts, the underlying causes of this neurodevelopmental disorder and its biomarkers remain unknown. However, advancements in artificial intelligence and machine learning have improved clinicians' ability to diagnose ASD. This review paper investigates various MRI modalities to identify distinct features that characterize individuals with ASD compared to typical control subjects. The review then moves on to explore deep learning models for ASD diagnosis, including convolutional neural networks (CNNs), autoencoders, graph convolutions, attention networks, and other models. CNNs and their variations are particularly effective due to their capacity to learn structured image representations and identify reliable biomarkers for brain disorders. Computer vision transformers often employ CNN architectures with transfer learning techniques like fine-tuning and layer freezing to enhance image classification performance, surpassing traditional machine learning models. This review paper contributes in three main ways. Firstly, it provides a comprehensive overview of a recommended architecture for using vision transformers in the systematic ASD diagnostic process. To this end, the paper investigates various pre-trained vision architectures such as VGG, ResNet, Inception, InceptionResNet, DenseNet, and Swin models that were fine-tuned for ASD diagnosis and classification. Secondly, it discusses the vision transformers of 2020th like BiT, ViT, MobileViT, and ConvNeXt, and applying transfer learning methods in relation to their prospective practicality in ASD classification. Thirdly, it explores brain transformers that are pre-trained on medically rich data and MRI neuroimaging datasets. The paper recommends a systematic architecture for ASD diagnosis using brain transformers. It also reviews recently developed brain transformer-based models, such as METAFormer, Com-BrainTF, Brain Network, ST-Transformer, STCAL, BolT, and BrainFormer, discussing their deep transfer learning architectures and results in ASD detection. Additionally, the paper summarizes and discusses brain-related transformers for various brain disorders, such as MSGTN, STAGIN, and MedTransformer, in relation to their potential usefulness in ASD. The study suggests that developing specialized transformer-based models, following the success of natural language processing (NLP), can offer new directions for image classification problems in ASD brain biomarkers learning and classification. By incorporating the attention mechanism, treating MRI modalities as sequence prediction tasks trained on brain disorder classification problems, and fine-tuned on ASD datasets, brain transformers can show a great promise in ASD diagnosis.

A new diagnostic autism spectrum disorder (DASD) strategy using ensemble diagnosis methodology based on blood tests

Autism Spectrum Disorder (ASD) is a complex neurodevelopmental disease that impacts a child's way of behavior and social communication. In early childhood, children with ASD typically exhibit symptoms such as difficulty in social interaction, limited interests, and repetitive behavior. Although there are symptoms of ASD disease, most people do not understand these symptoms and therefore do not have enough knowledge to determine whether or not a child has ASD. Thus, early detection of ASD children based on accurate diagnosis model based on Artificial Intelligence (AI) techniques is a critical process to reduce the spread of the disease and control it early. Through this paper, a new Diagnostic Autism Spectrum Disorder (DASD) strategy is presented to quickly and accurately detect ASD children. DASD contains two layers called Data Filter Layer (DFL) and Diagnostic Layer (DL). Feature selection and outlier rejection processes are performed in DFL to filter the ASD dataset from less important features and incorrect data before using the diagnostic or detection method in DL to accurately diagnose the patients. In DFL, Binary Gray Wolf Optimization (BGWO) technique is used to select the most significant set of features while Binary Genetic Algorithm (BGA) technique is used to eliminate invalid training data. Then, Ensemble Diagnosis Methodology (EDM) as a new diagnostic technique is used in DL to quickly and precisely diagnose ASD children. In this paper, the main contribution is EDM that consists of several diagnostic models including Enhanced K-Nearest Neighbors (EKNN) as one of them. EKNN represents a hybrid technique consisting of three methods called K-Nearest Neighbors (KNN), Naïve Bayes (NB), and Chimp Optimization Algorithm (COA). NB is used as a weighed method to convert data from feature space to weight space. Then, COA is used as a data generation method to reduce the size of training dataset. Finally, KNN is applied on the reduced data in weight space to quickly and accurately diagnose ASD children based on new training dataset with small size. ASD blood tests dataset is used to test the proposed DASD strategy against other recent strategies [1]. It is concluded that the DASD strategy is superior to other strategies based on many performance measures including accuracy, error, recall, precision, micro_average precision, macro_average precision, micro_average recall, macro_average recall, F1-measure, and implementation-time with values equal to 0.93, 0.07, 0.83, 0.82, 0.80, 0.83, 0.79, 0.81, 0.79, and 1.5 s respectively.

A face image classification method of autistic children based on the two-phase transfer learning

Autism spectrum disorder (ASD) is a neurodevelopmental disorder, which seriously affects children's normal life. Screening potential autistic children before professional diagnose is helpful to early detection and early intervention. Autistic children have some different facial features from non-autistic children, so the potential autistic children can be screened by taking children's facial images and analyzing them with a mobile phone. The area under curve (AUC) is a more robust metrics than accuracy in evaluating the performance of a model used to carry out the two-category classification, and the AUC of the deep learning model suitable for the mobile terminal in the existing research can be further improved. Moreover, the size of an input image is large, which is not fit for a mobile phone. A deep transfer learning method is proposed in this research, which can use images with smaller size and improve the AUC of existing studies. The proposed transfer method uses the two-phase transfer learning mode and the multi-classifier integration mode. For MobileNetV2 and MobileNetV3-Large that are suitable for a mobile phone, the two-phase transfer learning mode is used to improve their classification performance, and then the multi-classifier integration mode is used to integrate them to further improve the classification performance. A multi-classifier integrating calculation method is also proposed to calculate the final classification results according to the classifying results of the participating models. The experimental results show that compared with the one-phase transfer learning, the two-phase transfer learning can significantly improve the classification performance of MobileNetV2 and MobileNetV3-Large, and the classification performance of the integrated classifier is better than that of any participating classifiers. The accuracy of the integrated classifier in this research is 90.5%, and the AUC is 96.32%, which is 3.51% greater than the AUC (92.81%) of the previous studies.

Personalized estimates of brain cortical structural variability in individuals with Autism spectrum disorder: the predictor of brain age and neurobiology relevance

BACKGROUND

Autism spectrum disorder (ASD) is a heritable condition related to brain development that affects a person's perception and socialization with others. Here, we examined variability in the brain morphology in ASD children and adolescent individuals at the level of brain cortical structural profiles and the level of each brain regional measure.

METHODS

We selected brain structural MRI data in 600 ASDs and 729 normal controls (NCs) from Autism Brain Imaging Data Exchange (ABIDE). The personalized estimate of similarity between gray matter volume (GMV) profiles of an individual to that of others in the same group was assessed by using the person-based similarity index (PBSI). Regional contributions to PBSI score were utilized for brain age gap estimation (BrainAGE) prediction model establishment, including support vector regression (SVR), relevance vector regression (RVR), and Gaussian process regression (GPR). The association between BrainAGE prediction in ASD and clinical performance was investigated. We further explored the related inter-regional profiles of gene expression from the Allen Human Brain Atlas with variability differences in the brain morphology between groups.

RESULTS

The PBSI score of GMV was negatively related to age regardless of the sample group, and the PBSI score was significantly lower in ASDs than in NCs. The regional contributions to the PBSI score of 126 brain regions in ASDs showed significant differences compared to NCs. RVR model achieved the best performance for predicting brain age. Higher inter-individual brain morphology variability was related to increased brain age, specific to communication symptoms. A total of 430 genes belonging to various pathways were identified as associated with brain cortical morphometric variation. The pathways, including short-term memory, regulation of system process, and regulation of nervous system process, were dominated mainly by gene sets for manno midbrain neurotypes.

LIMITATIONS

There is a sample mismatch between the gene expression data and brain imaging data from ABIDE. A larger sample size can contribute to the model training of BrainAGE and the validation of the results.

CONCLUSIONS

ASD has personalized heterogeneity brain morphology. The brain age gap estimation and transcription-neuroimaging associations derived from this trait are replenished in an additional direction to boost the understanding of the ASD brain.

Machine learning for autism spectrum disorder diagnosis using structural magnetic resonance imaging: Promising but challenging

Autism spectrum disorder (ASD) is a complex neurodevelopmental disorder that affects approximately 1% of the population and causes significant burdens. ASD's pathogenesis remains elusive; hence, diagnosis is based on a constellation of behaviors. Structural magnetic resonance imaging (sMRI) studies have shown several abnormalities in volumetric and geometric features of the autistic brain. However, inconsistent findings prevented most contributions from being translated into clinical practice. Establishing reliable biomarkers for ASD using sMRI is crucial for the correct diagnosis and treatment. In recent years, machine learning (ML) and specifically deep learning (DL) have quickly extended to almost every sector, notably in disease diagnosis. Thus, this has led to a shift and improvement in ASD diagnostic methods, fulfilling most clinical diagnostic requirements. However, ASD discovery remains difficult. This review examines the ML-based ASD diagnosis literature over the past 5 years. A literature-based taxonomy of the research landscape has been mapped, and the major aspects of this topic have been covered. First, we provide an overview of ML's general classification pipeline and the features of sMRI. Next, representative studies are highlighted and discussed in detail with respect to methods, and biomarkers. Finally, we highlight many common challenges and make recommendations for future directions. In short, the limited sample size was the main obstacle; Thus, comprehensive data sets and rigorous methods are necessary to check the generalizability of the results. ML technologies are expected to advance significantly in the coming years, contributing to the diagnosis of ASD and helping clinicians soon.